Table 2: The inhibition rate (%) of paw oedema in rats at different time for different tetrandrine formulations and market dexamethasone ointment (positive control).

TimeEthosomesPositive controlLiposomesSolution
High doseMedium doseLow dose

Primary adjuvant arthritis
18 h36.8013.071.8516.511.321.60
66 h46.4816.977.1038.777.798.63

Secondary adjuvant arthritis
10 d66.0134.6244.7279.0743.3130.70
13 d62.6435.3744.0078.8142.7614.96
15 d67.6040.3641.9078.9942.2914.59
18 d70.9546.3341.1382.7253.9842.66